Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Cancer Chemotherapy and Pharmacology|December 14, 2018
Clinical outcomes of oral metronomic vinorelbine in advanced non-small cell lung cancer: correlations with pharmacokinetics and MDR1 polymorphismsMilena Gusella, Felice Pasini, Donatella Caruso, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2011
Combinations of polymorphisms in genes involved in the 5-Fluorouracil metabolism pathway are associated with gastrointestinal toxicity in chemotherapy-treated colorectal cancer patientsShoaib Afzal, Milena Gusella, Ben Vainer, et al.Plos One|August 21, 2019
An individual patient-data meta-analysis of metronomic oral vinorelbine in metastatic non-small cell lung cancerJean-Louis Pujol, Amandine Coffy, Andrea Camerini, et al.Tumori|March 11, 2011
Positive experience of intraperitoneal chemotherapy followed by intravenous chemotherapy in heavily pretreated patients with suboptimal residual ovarian cancer and primary peritoneal cancerMaria Ornella Nicoletto, Maurizia Dalla Palma, Martin E Donach, et al.Pharmacology Research & Perspectives|August 20, 2020
Predicting steady-state endoxifen plasma concentrations in breast cancer patients by CYP2D6 genotyping or phenotyping. Which approach is more reliable?Milena Gusella, Felice Pasini, Barbara Corso, et al.International Journal of Environmental Research and Public Health|December 9, 2020
Early Phase Management of the SARS-CoV-2 Pandemic in the Geographic Area of the Veneto Region, in One of the World's Oldest PopulationsAlessandro Camerotto, Andrea Sartorio, Anna Mazzetto, et al.Pharmacogenomics|September 17, 2011
The association of polymorphisms in 5-fluorouracil metabolism genes with outcome in adjuvant treatment of colorectal cancerShoaib Afzal, Milena Gusella, Søren Astrup Jensen, et al.Oncotarget|April 22, 2017
Assessment of the interlaboratory variability and robustness of JAK2V617F mutation assays: A study involving a consortium of 19 Italian laboratoriesMargherita Perricone, Francesca Palandri, Emanuela Ottaviani, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 5, 2014
Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysisDan Rosmarin, Claire Palles, David Church, et al.Pageof 3